Circulating microRNA: The Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy, a Pilot Study.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jan 2021
Historique:
received: 22 12 2020
revised: 06 01 2021
accepted: 10 01 2021
entrez: 15 1 2021
pubmed: 16 1 2021
medline: 7 4 2021
Statut: epublish

Résumé

MicroRNAs (miRNAs) are small noncoding RNAs that have emerged as new potential epigenetic biomarkers. Here, we evaluate the efficacy of six circulating miRNA previously described in the literature as biomarkers for the diagnosis of temporal lobe epilepsy (TLE) and/or as predictive biomarkers to antiepileptic drug response. We measured the differences in serum miRNA levels by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) assays in a cohort of 27 patients (14 women and 13 men; mean ± SD age: 43.65 ± 17.07) with TLE compared to 20 healthy controls (HC) matched for sex, age and ethnicity (11 women and 9 men; mean ± SD age: 47.5 ± 9.1). Additionally, patients were classified according to whether they had drug-responsive (

Identifiants

pubmed: 33445780
pii: ijms22020702
doi: 10.3390/ijms22020702
pmc: PMC7828221
pii:
doi:

Substances chimiques

Biomarkers 0
Circulating MicroRNA 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Ministry of Education, University and Research (MIUR) [L.232/2016]. INTEROMICS flagship project (Interomics PB05), National Research Council CUP
ID : Grant B91JI2000190001

Références

Eur J Neurol. 2020 Apr;27(4):660-666
pubmed: 31746515
Ann Palliat Med. 2020 Sep;9(5):3194-3203
pubmed: 32954759
Neurology. 2016 Nov 1;87(18):1934-1942
pubmed: 27694267
Cell Res. 2010 Oct;20(10):1158-69
pubmed: 20856265
Sci Rep. 2017 Sep 14;7(1):11592
pubmed: 28912503
Oncotarget. 2017 Jul 11;8(28):45040-45041
pubmed: 28589912
Pharmacol Res. 2016 Nov;113(Pt A):421-425
pubmed: 27659220
Open Access Maced J Med Sci. 2019 Dec 10;7(23):3965-3969
pubmed: 32165937
PLoS One. 2014 Jan 15;9(1):e85617
pubmed: 24454901
Clin Chem. 2015 Nov;61(11):1333-42
pubmed: 26408530
J Neurol Neurosurg Psychiatry. 2011 May;82(5):555-9
pubmed: 20971758
Neurobiol Dis. 2006 Oct;24(1):202-11
pubmed: 16928449
Drug Des Devel Ther. 2013 Dec 03;7:1447-54
pubmed: 24348021
Mol Ther Nucleic Acids. 2018 Dec 7;13:275-290
pubmed: 30321815
Epilepsia. 2011 Jun;52(6):1195-7; discussion 1205-9
pubmed: 21671927
Epilepsy Behav. 2015 Sep;50:162-70
pubmed: 26159729
Neurology. 2016 May 17;86(20):1904-10
pubmed: 27164663
Inflamm Res. 2019 Dec;68(12):993-998
pubmed: 31511910
Epilepsy Curr. 2020 Jan-Feb;20(1):33-38
pubmed: 31791133
PLoS One. 2014 Jan 27;9(1):e85843
pubmed: 24475055
Epilepsia. 2011 Apr;52(4):712-7
pubmed: 21453353
Int J Mol Sci. 2017 Jan 27;18(2):
pubmed: 28134831
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Front Mol Neurosci. 2018 Jun 15;11:208
pubmed: 29962935
Bioinformatics. 2005 Oct 15;21(20):3940-1
pubmed: 16096348
J Cereb Blood Flow Metab. 2010 Jan;30(1):92-101
pubmed: 19724284
Methods. 2010 Apr;50(4):298-301
pubmed: 20146939
Indian J Hum Genet. 2011 May;17 Suppl 1:S12-21
pubmed: 21747582
Trends Mol Med. 2011 Aug;17(8):412-23
pubmed: 21652264
Neuroimage. 2011 Jun 1;56(3):907-22
pubmed: 21352927
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
Front Mol Neurosci. 2013 Nov 12;6:37
pubmed: 24282394
Clin Rheumatol. 2019 Mar;38(3):877-884
pubmed: 30511295
EBioMedicine. 2018 Dec;38:127-141
pubmed: 30396857
J Mol Neurosci. 2015 Feb;55(2):466-79
pubmed: 25078263
Cell Mol Life Sci. 2014 Feb;71(3):499-516
pubmed: 23771630
Epilepsia Open. 2018 Oct 30;3(4):427-436
pubmed: 30525113
Curr Neuropharmacol. 2018;16(1):37-42
pubmed: 28676013
Eur J Neurosci. 2010 Mar;31(6):1100-7
pubmed: 20214679
Science. 2005 Sep 2;309(5740):1573-6
pubmed: 16081698
Epilepsia. 2010 Apr;51(4):506-10
pubmed: 19780790
Dis Model Mech. 2018 Mar 23;11(3):
pubmed: 29590637

Auteurs

Selene De Benedittis (S)

Department of Medical and Surgical Sciences, Institute of Neurology, University "Magna Graecia", Germaneto, 88100 Catanzaro, Italy.

Francesco Fortunato (F)

Department of Medical and Surgical Sciences, Institute of Neurology, University "Magna Graecia", Germaneto, 88100 Catanzaro, Italy.

Claudia Cava (C)

Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Via F.Cervi 93, 20090 Segrate-Milan, Italy.

Francesca Gallivanone (F)

Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Via F.Cervi 93, 20090 Segrate-Milan, Italy.

Enrico Iaccino (E)

Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Maria Eugenia Caligiuri (ME)

Neuroscience Research Center, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Isabella Castiglioni (I)

Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Via F.Cervi 93, 20090 Segrate-Milan, Italy.
Department of Physics "Giuseppe Occhialini", University of Milan-Bicocca, Piazza della Scienza 3, 20126 Milan, Italy.

Gloria Bertoli (G)

Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Via F.Cervi 93, 20090 Segrate-Milan, Italy.

Ida Manna (I)

Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Section of Germaneto, 88100 Catanzaro, Italy.

Angelo Labate (A)

Department of Medical and Surgical Sciences, Institute of Neurology, University "Magna Graecia", Germaneto, 88100 Catanzaro, Italy.

Antonio Gambardella (A)

Department of Medical and Surgical Sciences, Institute of Neurology, University "Magna Graecia", Germaneto, 88100 Catanzaro, Italy.
Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Section of Germaneto, 88100 Catanzaro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH